FUTURE FOCUS
Moving forward with intention
Employers are entering 2026 in an environment defined by higher trends, intense renewal pressure, and growing financial strain for both organizations and employees. Rising specialty prescription costs; large claims; GLP-1 costs, utilization, and new indications; tariffs; gene therapies; economic uncertainty; and more are all shaping a strained landscape that isn’t easing anytime soon.
Going forward, employers need sharp direction, clear priorities, and a willingness to use creativity, technology, and clinical insight to their advantage.
Organizations that act early and decisively will be better positioned to manage volatility and guide their people to the right care.
More on key areas to watch in 2026:
GLP-1s
Expanding indications, rising demand, and new employer strategy questions will become even more urgent next year.
Pharmacy shifts
Potential cost and compliance impacts tied to federal pricing and transparency changes — including DTC and TrumpRx proposals, 340B adjustments, and most-favored nation pricing considerations — will be key to watch ahead.
